TFS Articles
Search by keyword, or choose a Focus Topic to view all articles within that area of study.
Search by keyword, or choose a Focus Topic to view all articles within that area of study.
TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
Read NowMost CROs bring patient groups in after the protocol is locked. TFS HealthScience explains why that timing determines whether co-design actually works.
Read NowFrom site selection to protocol design, inclusive trials produce better science. TFS HealthScience on closing the representation gap.
Read NowLGBTQ+ patients want to take part in clinical research. Most are never asked. Here is what the science says and what better recruitment looks like in practice.
Read NowBiomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
Read NowLearn how ARVO 2026 signals a new era of precision ophthalmology, where smarter recruitment, imaging consistency and patient‑centric design demand deep‑tier partnerships like those offered by TFS.
Read NowThe FDA reminded over 2,200 sponsors to submit overdue ClinicalTrials.gov results. This how TFS Medical Writing team can help.
Read NowExperienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Read NowPsoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.
Read Now